Mark G. Currie
2016
In 2016, Mark G. Currie earned a total compensation of $1.9M as Former Senior Vice President, Chief Scientific Officer and President of R&D at Ironwood Pharmaceuticals, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $301,000 |
|---|---|
| Option Awards | $1,092,045 |
| Salary | $454,000 |
| Other | $8,040 |
| Total | $1,855,085 |
Currie received $1.1M in option awards, accounting for 59% of the total pay in 2016.
Currie also received $301K in non-equity incentive plan, $454K in salary and $8K in other compensation.
Rankings
In 2016, Mark G. Currie's compensation ranked 5,227th out of 14,075 executives tracked by ExecPay. In other words, Currie earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,227 out of 14,075 | 63rd |
Division Manufacturing | 1,878 out of 5,489 | 66th |
Major group Chemicals And Allied Products | 595 out of 1,895 | 69th |
Industry group Drugs | 445 out of 1,538 | 71st |
Industry Pharmaceutical Preparations | 354 out of 1,176 | 70th |
Source: SEC filing on April 26, 2019.
Currie's colleagues
We found two more compensation records of executives who worked with Mark G. Currie at Ironwood Pharmaceuticals in 2016.